Cargando…

Expression of Bcl-2 and Bad in hippocampus of status epileptic rats and molecular mechanism of intervened recombinant human erythropoietin

Injury of hippocampal neurons in status epilepticus (SE) SD rats kindled by pentylenetetrazol (PTZ) were studied, and the changes of apoptosis neurons, protein expression of Bad and Bcl-2 alone and combined application of phosphatidyl inositol 3-kinase (PI3K) inhibitor LY294002 and recombinant human...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Jianghua, Shi, Zhiqin, Su, Xudong, Zhou, Yi, Li, Bin, Wang, Shan, Jia, Lijing, Zhao, Bo, Zhu, Mengchu, Feng, Xiaohong, Yin, Kuochang, Wang, Weiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090305/
https://www.ncbi.nlm.nih.gov/pubmed/30116338
http://dx.doi.org/10.3892/etm.2018.6250
_version_ 1783347176318959616
author Yu, Jianghua
Shi, Zhiqin
Su, Xudong
Zhou, Yi
Li, Bin
Wang, Shan
Jia, Lijing
Zhao, Bo
Zhu, Mengchu
Feng, Xiaohong
Yin, Kuochang
Wang, Weiping
author_facet Yu, Jianghua
Shi, Zhiqin
Su, Xudong
Zhou, Yi
Li, Bin
Wang, Shan
Jia, Lijing
Zhao, Bo
Zhu, Mengchu
Feng, Xiaohong
Yin, Kuochang
Wang, Weiping
author_sort Yu, Jianghua
collection PubMed
description Injury of hippocampal neurons in status epilepticus (SE) SD rats kindled by pentylenetetrazol (PTZ) were studied, and the changes of apoptosis neurons, protein expression of Bad and Bcl-2 alone and combined application of phosphatidyl inositol 3-kinase (PI3K) inhibitor LY294002 and recombinant human erythropoietin (rHuEpo) were evaluated for the possible mechanisms of rHuEpo. The SE rats kindled by the PTZ were randomly divided into normal control group [normal saline (NS)], model group (PTZ + NS), rHuEpo treated group (PTZ + rHuEpo), LY294002 treated group (PTZ + LY294002 + rHuEpo) and LY294002 control group (rHuEpo + PTZ + DMSO). Apoptosis of hippocampal neurons was detected by TUNEL method; expression of phosphorylation protein kinase B (p-PKB/p-Akt), Bcl-2 and Bad were detected by immunohistochemistry; the expression of Bcl-2 mRNA, Bad mRNA in hippocampal neurons of rats were detected through reverse transcription polymerase chain reaction (RT-PCR); the expression of Akt, p-Akt and Bcl-2, Bad protein in hippocampal neurons of rats were detected by western blotting. The amount of apoptotic neurons was less in the rHuEpo treated group and the LY294002 control group than in the LY294002 treated group (P<0.05). The expression of p-Akt protein and Bcl-2 protein increased while the Bad protein decreased significantly in the rHuEpo treated group and the LY294002 control group compared with the LY294002 treated group (P<0.05). The expression of Bad protein and Bad mRNA in hippocampus increased while the p-Akt, Bcl-2, Bcl-2 mRNA decreased significantly in the LY294002 treated group compared with the rHuEpo treated group (P<0.05). The PI3K/Akt signaling pathway is one of the pathways of rHuEpo neuroprotective effects and was confirmed from both the of positive and negative aspects. rHuEpo regulates the expression of mitochondrial apoptotic pathway related factors Bad and Bcl-2 to inhibit apoptosis and promotes neuronal survival.
format Online
Article
Text
id pubmed-6090305
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-60903052018-08-16 Expression of Bcl-2 and Bad in hippocampus of status epileptic rats and molecular mechanism of intervened recombinant human erythropoietin Yu, Jianghua Shi, Zhiqin Su, Xudong Zhou, Yi Li, Bin Wang, Shan Jia, Lijing Zhao, Bo Zhu, Mengchu Feng, Xiaohong Yin, Kuochang Wang, Weiping Exp Ther Med Articles Injury of hippocampal neurons in status epilepticus (SE) SD rats kindled by pentylenetetrazol (PTZ) were studied, and the changes of apoptosis neurons, protein expression of Bad and Bcl-2 alone and combined application of phosphatidyl inositol 3-kinase (PI3K) inhibitor LY294002 and recombinant human erythropoietin (rHuEpo) were evaluated for the possible mechanisms of rHuEpo. The SE rats kindled by the PTZ were randomly divided into normal control group [normal saline (NS)], model group (PTZ + NS), rHuEpo treated group (PTZ + rHuEpo), LY294002 treated group (PTZ + LY294002 + rHuEpo) and LY294002 control group (rHuEpo + PTZ + DMSO). Apoptosis of hippocampal neurons was detected by TUNEL method; expression of phosphorylation protein kinase B (p-PKB/p-Akt), Bcl-2 and Bad were detected by immunohistochemistry; the expression of Bcl-2 mRNA, Bad mRNA in hippocampal neurons of rats were detected through reverse transcription polymerase chain reaction (RT-PCR); the expression of Akt, p-Akt and Bcl-2, Bad protein in hippocampal neurons of rats were detected by western blotting. The amount of apoptotic neurons was less in the rHuEpo treated group and the LY294002 control group than in the LY294002 treated group (P<0.05). The expression of p-Akt protein and Bcl-2 protein increased while the Bad protein decreased significantly in the rHuEpo treated group and the LY294002 control group compared with the LY294002 treated group (P<0.05). The expression of Bad protein and Bad mRNA in hippocampus increased while the p-Akt, Bcl-2, Bcl-2 mRNA decreased significantly in the LY294002 treated group compared with the rHuEpo treated group (P<0.05). The PI3K/Akt signaling pathway is one of the pathways of rHuEpo neuroprotective effects and was confirmed from both the of positive and negative aspects. rHuEpo regulates the expression of mitochondrial apoptotic pathway related factors Bad and Bcl-2 to inhibit apoptosis and promotes neuronal survival. D.A. Spandidos 2018-08 2018-06-05 /pmc/articles/PMC6090305/ /pubmed/30116338 http://dx.doi.org/10.3892/etm.2018.6250 Text en Copyright: © Yu et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Yu, Jianghua
Shi, Zhiqin
Su, Xudong
Zhou, Yi
Li, Bin
Wang, Shan
Jia, Lijing
Zhao, Bo
Zhu, Mengchu
Feng, Xiaohong
Yin, Kuochang
Wang, Weiping
Expression of Bcl-2 and Bad in hippocampus of status epileptic rats and molecular mechanism of intervened recombinant human erythropoietin
title Expression of Bcl-2 and Bad in hippocampus of status epileptic rats and molecular mechanism of intervened recombinant human erythropoietin
title_full Expression of Bcl-2 and Bad in hippocampus of status epileptic rats and molecular mechanism of intervened recombinant human erythropoietin
title_fullStr Expression of Bcl-2 and Bad in hippocampus of status epileptic rats and molecular mechanism of intervened recombinant human erythropoietin
title_full_unstemmed Expression of Bcl-2 and Bad in hippocampus of status epileptic rats and molecular mechanism of intervened recombinant human erythropoietin
title_short Expression of Bcl-2 and Bad in hippocampus of status epileptic rats and molecular mechanism of intervened recombinant human erythropoietin
title_sort expression of bcl-2 and bad in hippocampus of status epileptic rats and molecular mechanism of intervened recombinant human erythropoietin
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090305/
https://www.ncbi.nlm.nih.gov/pubmed/30116338
http://dx.doi.org/10.3892/etm.2018.6250
work_keys_str_mv AT yujianghua expressionofbcl2andbadinhippocampusofstatusepilepticratsandmolecularmechanismofintervenedrecombinanthumanerythropoietin
AT shizhiqin expressionofbcl2andbadinhippocampusofstatusepilepticratsandmolecularmechanismofintervenedrecombinanthumanerythropoietin
AT suxudong expressionofbcl2andbadinhippocampusofstatusepilepticratsandmolecularmechanismofintervenedrecombinanthumanerythropoietin
AT zhouyi expressionofbcl2andbadinhippocampusofstatusepilepticratsandmolecularmechanismofintervenedrecombinanthumanerythropoietin
AT libin expressionofbcl2andbadinhippocampusofstatusepilepticratsandmolecularmechanismofintervenedrecombinanthumanerythropoietin
AT wangshan expressionofbcl2andbadinhippocampusofstatusepilepticratsandmolecularmechanismofintervenedrecombinanthumanerythropoietin
AT jialijing expressionofbcl2andbadinhippocampusofstatusepilepticratsandmolecularmechanismofintervenedrecombinanthumanerythropoietin
AT zhaobo expressionofbcl2andbadinhippocampusofstatusepilepticratsandmolecularmechanismofintervenedrecombinanthumanerythropoietin
AT zhumengchu expressionofbcl2andbadinhippocampusofstatusepilepticratsandmolecularmechanismofintervenedrecombinanthumanerythropoietin
AT fengxiaohong expressionofbcl2andbadinhippocampusofstatusepilepticratsandmolecularmechanismofintervenedrecombinanthumanerythropoietin
AT yinkuochang expressionofbcl2andbadinhippocampusofstatusepilepticratsandmolecularmechanismofintervenedrecombinanthumanerythropoietin
AT wangweiping expressionofbcl2andbadinhippocampusofstatusepilepticratsandmolecularmechanismofintervenedrecombinanthumanerythropoietin